Related references
Note: Only part of the references are listed.Gut microbiota: impacts on gastrointestinal cancer immunotherapy
Harry Cheuk Hay Lau et al.
GUT MICROBES (2021)
Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
Yangyang She et al.
CANCER CELL INTERNATIONAL (2020)
The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction
Hongzhi Quan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Malignant transformation of oral leukoplakia is associated with macrophage polarization
Manuel Weber et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy
Francesco Perri et al.
TRANSLATIONAL ONCOLOGY (2020)
Molecular Diagnostics in Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma
Katherine C. Wai et al.
CELLS (2020)
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas
Mario Sanchez-Canteli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers
Susumu Suzuki et al.
CANCER SCIENCE (2020)
Tumor-associated macrophages
Luca Cassetta et al.
CURRENT BIOLOGY (2020)
Immune escape mechanisms in head and neck squamous cell carcinoma and implication for new immunotherapy approach
Marco C. Merlano et al.
CURRENT OPINION IN ONCOLOGY (2020)
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
Qiyao Yang et al.
ACTA PHARMACEUTICA SINICA B (2020)
HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
Jerome R. Lechien et al.
CANCERS (2020)
Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression
Faustino J. Suarez-Sanchez et al.
CANCERS (2020)
Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs
Yiling Meng et al.
BIOMARKERS IN MEDICINE (2020)
The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
Niels E. Wondergem et al.
CURRENT ONCOLOGY REPORTS (2020)
Tumor microenvironment characterization in head and neck cancer identifies prognostic and immunotherapeutically relevant gene signatures
Mengqi Huo et al.
SCIENTIFIC REPORTS (2020)
Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice
Hui-Ching Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
Shumin Li et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Irina Larionova et al.
FRONTIERS IN ONCOLOGY (2020)
PD-L1 CPS Scoring Accuracy in Small Biopsies and Aspirate Cell Blocks from Patients with Head and Neck Squamous Cell Carcinoma
Ajit S. Paintal et al.
HEAD & NECK PATHOLOGY (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
Sun Min Lim et al.
CANCER RESEARCH AND TREATMENT (2019)
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort
Neil H. Segal et al.
EUROPEAN JOURNAL OF CANCER (2019)
Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis
Huayu Yang et al.
FRONTIERS IN ONCOLOGY (2019)
Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
Rasha Abu Eid
FRONTIERS IN ONCOLOGY (2019)
Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
Jacob H. Rasmussen et al.
BRITISH JOURNAL OF CANCER (2019)
The B-Side of Cancer Immunity: The Underrated Tune
Anne Largeot et al.
CELLS (2019)
Prognostic Value of the Neo-Immunoscore in Renal Cell Carcinoma
Congfang Guo et al.
FRONTIERS IN ONCOLOGY (2019)
Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis
Giuseppe Troiano et al.
ORAL ONCOLOGY (2019)
Head and neck cancer: searching for genomic and epigenetic biomarkers in body fluids - the state of art
Ilda Patricia Ribeiro et al.
MOLECULAR CYTOGENETICS (2019)
Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
Madison Canning et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
The relevance between the immune response- related gene module and clinical traits in head and neck squamous cell carcinoma
Yidan Song et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review
Jerome R. Lechien et al.
CELLS (2019)
Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
Panagiota Economopoulou et al.
FRONTIERS IN ONCOLOGY (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
CD206+ tumor-associated macrophages promote proliferation and invasion in oral squamous cell carcinoma via EGF production
A. S. M. Rafiul Haque et al.
SCIENTIFIC REPORTS (2019)
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy
Y. -P. Chen et al.
ANNALS OF ONCOLOGY (2019)
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
M. Oliva et al.
ANNALS OF ONCOLOGY (2019)
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Maria Teresa Masucci et al.
FRONTIERS IN ONCOLOGY (2019)
Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions
Albrecht Stenzinger et al.
GENES CHROMOSOMES & CANCER (2019)
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
Patrick A. Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Characteristics and impact of programmed death-ligand 1 expression, CD8+tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma
Nuttapong Ngamphaiboon et al.
MEDICAL ONCOLOGY (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Bioinformatic Analysis Reveals an Immune/Inflammatory-Related Risk Signature for Oral Cavity Squamous Cell Carcinoma
Shuang Bai et al.
JOURNAL OF ONCOLOGY (2019)
Identification and Validation of an Immune-Related RNA Signature to Predict Survival of Patients With Head and Neck Squamous Cell Carcinoma
Shuo Wu et al.
FRONTIERS IN GENETICS (2019)
Elevated CD163+/CD68+ Ratio at Tumor Invasive Front is Closely Associated with Aggressive Phenotype and Poor Prognosis in Colorectal Cancer
Chaogang Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy
Joshua D. Horton et al.
TRENDS IN CANCER (2019)
Expression of PD-1/PD-L1 in head and neck squamous cell carcinoma and its clinical significance
Shu-Wei Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy
Liisa Chang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)
Concordance of PD-L1 Expression Between Core Biopsy and Resection Specimens of Non-Small Cell Lung Cancer
Sarah E. Gradecki et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer
Jurgita Jackute et al.
BMC IMMUNOLOGY (2018)
The oral microbiota - a mechanistic role for systemic diseases
G. Jia et al.
BRITISH DENTAL JOURNAL (2018)
Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review
Feifei Teng et al.
CANCER LETTERS (2018)
The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis
Tristan Tham et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2018)
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas
Alexis Desrichard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
Ming Sound Tsao et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
The intratumoral distribution influences the prognostic impact of CD68-and CD204-positive macrophages in non-small cell lung cancer
Zhuo Li et al.
LUNG CANCER (2018)
Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinoma
Magalie P. Tardy et al.
ORAL ONCOLOGY (2018)
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas
Alexis Desrichard et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial
A. D. Colevas et al.
ANNALS OF ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta-analysis
Yukinori Takenaka et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis
Wei-fa Yang et al.
ORAL ONCOLOGY (2018)
Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas
Won Jin Ho et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
The molecular landscape of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2018)
Frameshift events predict anti-PD-1/L1 response in head and neck cancer
Glenn J. Hanna et al.
JCI INSIGHT (2018)
The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer
R. Alex Harbison et al.
JCI INSIGHT (2018)
Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck
Wen-Cheng Chen et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis
Elena-Sophie Prigge et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics
Georgia Karpathiou et al.
ONCOTARGET (2017)
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
Joshua Bauml et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma
Kate Poropatich et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2017)
New insights into the role of EMT in tumor immune escape
Stephane Terry et al.
MOLECULAR ONCOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes
Astrid De Meulenaere et al.
PATHOLOGY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma
Xiangrui Ma et al.
ONCOTARGET (2017)
MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review
Jung Han Kim et al.
ONCOTARGET (2017)
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
Axel Lechner et al.
ONCOTARGET (2017)
Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer
Astrid De Meulenaere et al.
ONCOTARGET (2017)
The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis
Emma J. de Ruiter et al.
ONCOIMMUNOLOGY (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Athanassios Argiris et al.
FRONTIERS IN ONCOLOGY (2017)
Microbial Communities Associated with Primary and Metastatic Head and Neck Squamous Cell Carcinoma - A High Fusobacterial and Low Streptococcal Signature
Jae M. Shin et al.
SCIENTIFIC REPORTS (2017)
Tumor-infiltrating CD45RO+ Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors
Guoming Hu et al.
SCIENTIFIC REPORTS (2017)
A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma
Wei Sun et al.
BRITISH JOURNAL OF CANCER (2017)
The gastrointestinal microbiota and its role in oncogenesis
S. Y. Lam et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?
Astrid De Meulenaere et al.
HEAD & NECK PATHOLOGY (2017)
Biomarkers of response to PD-1/PD-L1 inhibition
Saman Maleki Vareki et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Evaluation of oral microbiome profiling as a response biomarker in squamous cell carcinoma of the head and neck: Analyses from CheckMate 141
Robert L. Ferris et al.
CANCER RESEARCH (2017)
Landscape of Microsatellite Instability Across 39 Cancer Types
Russell Bonneville et al.
JCO PRECISION ONCOLOGY (2017)
Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies
M. Ilie et al.
ANNALS OF ONCOLOGY (2016)
CD8+tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)
Panagiotis Balermpas et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
P. F. Ferrucci et al.
ANNALS OF ONCOLOGY (2016)
Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy
Hideyuki Takahashi et al.
CANCER SCIENCE (2016)
The Basis of Oncoimmunology
A. Karolina Palucka et al.
CELL (2016)
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
Alexander Martens et al.
CLINICAL CANCER RESEARCH (2016)
Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck
Sandra Schmitz et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Classification of TP53 mutations and HPV predict survival in advanced larynx cancer
Adam Scheel et al.
LARYNGOSCOPE (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus
Mark E. Zafereo et al.
ORAL ONCOLOGY (2016)
Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas
Nadege Kindt et al.
ORAL ONCOLOGY (2016)
Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer
Ruth J. Davis et al.
ORAL ONCOLOGY (2016)
The cancer immunogram
Christian U. Blank et al.
SCIENCE (2016)
CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity
Melanie Straub et al.
ONCOTARGET (2016)
The PD1:PD-L1/2 Pathway from Discovery to Clinical implementation
Kankana Bardhan et al.
FRONTIERS IN IMMUNOLOGY (2016)
Total mutation burden (TMB) in lung cancer (LC) and relationship with response to PD-1/PD-L1 targeted therapies.
David R. Spigel et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma
K. Oguejiofor et al.
BRITISH JOURNAL OF CANCER (2015)
Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas-an immunohistochemical study
M. Weber et al.
BRITISH JOURNAL OF CANCER (2015)
Immunology and Immunotherapy of Head and Neck Cancer
Robert L. Ferris
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas et al.
LANCET ONCOLOGY (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: A preliminary study
Gregory T. Wolf et al.
ORAL ONCOLOGY (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Prognostic significance of the tumour-adjacent tissue in head and neck cancers
Martina Raudenska et al.
TUMOR BIOLOGY (2015)
Therapeutic Insights from Genomic Studies of Head and Neck Squamous Cell Carcinomas
Peter S. Hammerman et al.
CANCER DISCOVERY (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Donald T. Weed et al.
CLINICAL CANCER RESEARCH (2015)
Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas
Tanguy Y. Seiwert et al.
CLINICAL CANCER RESEARCH (2015)
Alcohol and tobacco consumption affects bacterial richness in oral cavity mucosa biofilms
Andrew Maltez Thomas et al.
BMC MICROBIOLOGY (2014)
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
M. J. Ward et al.
BRITISH JOURNAL OF CANCER (2014)
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
P. Balermpas et al.
BRITISH JOURNAL OF CANCER (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
The interplay between HPV and host immunity in head and neck squamous cell carcinoma
Anne Skou Andersen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Small oral squamous cell carcinomas with nodal lymphogenic metastasis show increased infiltration of M2 polarized macrophages - An immunohistochemical analysis
Manuel Weber et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2014)
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours
Jerome Galon et al.
JOURNAL OF PATHOLOGY (2014)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
Charles G. Drake et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
Meiying Zhang et al.
JOURNAL OF OVARIAN RESEARCH (2014)
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cecile Badoual et al.
CANCER RESEARCH (2013)
CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma
Cecilia Nordfors et al.
EUROPEAN JOURNAL OF CANCER (2013)
Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma
Marileia Chaves Andrade et al.
HUMAN IMMUNOLOGY (2013)
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
David Vasquez-Dunddel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients
A. W. Turksma et al.
ORAL DISEASES (2013)
Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma
Claudia A. Dumitru et al.
FRONTIERS IN IMMUNOLOGY (2013)
Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck
Hanneke Stegeman et al.
BMC CANCER (2012)
Cellular Constituents of Immune Escape within the Tumor Microenvironment
Sid P. Kerkar et al.
CANCER RESEARCH (2012)
Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck
Kazuaki Chikamatsu et al.
CANCER SCIENCE (2012)
Infiltrating lymphocytes and human papillomavirus-16-associated oropharyngeal cancer
Derrick Wansom et al.
LARYNGOSCOPE (2012)
The Role of the Tumor Microenvironment in Regulating Angiogenesis
Randolph S. Watnick
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Analysis of microsatellite instability in laryngeal squamous cell carcinoma
Jorge Garcia Martinez et al.
ACTA OTORRINOLARINGOLOGICA ESPANOLA (2012)
Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease
Sokratis Trellakis et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma
Young-Ah Cho et al.
ORAL ONCOLOGY (2011)
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
Marloes Gooden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced
Claudia Lill et al.
WIENER KLINISCHE WOCHENSCHRIFT (2011)
Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck
Jan Boucek et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma
E. Zancope et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2010)
Assessment of microsatellite instability in head and neck cancer using consensus markers
Zubeyde Yalniz et al.
MOLECULAR BIOLOGY REPORTS (2010)
Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma
Yoshiko Watanabe et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2010)
Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma
Dominik Pretscher et al.
BMC CANCER (2009)
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara et al.
IMMUNITY (2009)
How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease
V. O. Puntmann
POSTGRADUATE MEDICAL JOURNAL (2009)
Association between p53 and human papillomavirus in head and neck cancer survival
Elaine M. Smith et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Prognostic versus predictive value of biomarkers in oncology
C. N. A. M. Oldenhuis et al.
EUROPEAN JOURNAL OF CANCER (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Inflammatory cell infiltration of tumors: Jekyll or Hyde
James E. Talmadge et al.
CANCER AND METASTASIS REVIEWS (2007)
The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review
Harlinde De Schutter et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
R. Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma
Johan W. Molling et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
Jan B. Vermorken et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers
C Badoual et al.
CLINICAL CANCER RESEARCH (2006)
Frequent microsatellite alterations of chromosome locus 4q13.1 in oral squamous cell carcinomas
SC Lin et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2005)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
Share Paper
